Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 265,000 | 189,000 | 94,000 | 996,000 | 854,000 |
| Depreciation Amortization | 239,000 | 159,000 | 79,000 | 295,000 | 222,000 |
| Income taxes - deferred | -17,000 | 2,000 | -7,000 | 23,000 | 3,000 |
| Accounts receivable | 32,000 | -16,000 | 16,000 | 47,000 | -87,000 |
| Accounts payable and accrued liabilities | -205,000 | -287,000 | -177,000 | 64,000 | 64,000 |
| Other Working Capital | -219,000 | -373,000 | -210,000 | -173,000 | -177,000 |
| Other Operating Activity | 155,000 | 288,000 | 161,000 | -112,000 | 2,000 |
| Operating Cash Flow | $250,000 | $-38,000 | $-44,000 | $1,140,000 | $881,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -385,000 | -257,000 | -133,000 | -498,000 | -344,000 |
| Net Acquisitions | -3,000 | 1,000 | N/A | 9,000 | 9,000 |
| Other Investing Activity | 1,000 | 0 | -1,000 | 2,000 | 8,000 |
| Investing Cash Flow | $-387,000 | $-256,000 | $-134,000 | $-487,000 | $-327,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 125,000 | N/A | N/A | N/A | N/A |
| Debt Issued | 150,000 | 150,000 | N/A | 520,000 | 520,000 |
| Debt Repayment | -167,000 | -6,000 | -3,000 | -708,000 | -704,000 |
| Common Stock Issued | 8,000 | 8,000 | 6,000 | 16,000 | 15,000 |
| Common Stock Repurchased | -322,000 | -322,000 | -255,000 | -644,000 | -520,000 |
| Dividend Paid | -124,000 | -83,000 | -42,000 | -148,000 | -106,000 |
| Other Financing Activity | -30,000 | -30,000 | -30,000 | -29,000 | -28,000 |
| Financing Cash Flow | $-360,000 | $-283,000 | $-324,000 | $-993,000 | $-823,000 |
| Exchange Rate Effect | -10,000 | 6,000 | -2,000 | -15,000 | -12,000 |
| Beginning Cash Position | 1,201,000 | 1,201,000 | 1,201,000 | 1,556,000 | 1,556,000 |
| End Cash Position | 694,000 | 630,000 | 697,000 | 1,201,000 | 1,275,000 |
| Net Cash Flow | $-507,000 | $-571,000 | $-504,000 | $-355,000 | $-281,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 250,000 | -38,000 | -44,000 | 1,140,000 | 881,000 |
| Capital Expenditure | -385,000 | -257,000 | -133,000 | -498,000 | -344,000 |
| Free Cash Flow | -135,000 | -295,000 | -177,000 | 642,000 | 537,000 |